Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 4/20 | 0.41 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.37 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.37 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.37 |
| ▸ | PRMT8 | Q9NR22 | 1/20 | 0.37 |
| ▸ | KDM1A | O60341 | 1/20 | 0.35 |
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | HTR7 | P34969 | 1/20 | 0.31 |
| ▸ | PHGDH | O43175 | 1/20 | 0.31 |
| ▸ | MGLL | Q99685 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17918916 | 0.84 | ACHE (0.39) | ACHECARM1PRMT6PRMT1PRMT8 | |
| SCHEMBL13827594 | 0.79 | KDM1A (0.31) | KDM1A | |
| SCHEMBL12403185 | 0.79 | KDM1A (0.34) | KDM1A | |
| SCHEMBL27305461 | 0.76 | ACHE (0.35) | ACHE | |
| SCHEMBL18501635 | 0.76 | ACHE (0.36) | ACHECARM1PRMT6PRMT1PRMT8 | |
| SCHEMBL26510209 | 0.76 | ACHE (0.36) | ACHECARM1PRMT6PRMT1PRMT8 | |
| SCHEMBL13827716 | 0.74 | KDM4E (0.39) | HRH3HTT | |
| SCHEMBL27307675 | 0.74 | GNAI3 (0.40) | — | |
| SCHEMBL25547692 | 0.72 | KDM4E (0.31) | — | |
| SCHEMBL21218082 | 0.72 | KDM4E (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024055112-A1 | BIFUNCTIONAL COMPOUNDS AND PHARMACEUTICAL USES THEREOF | Risen (Suzhou) Pharma Tech Co., Ltd. (CN) | 2024-03-21 | — | — | WO | disclosed |